Skip to main content

Published locations for Targeted Therapy Thwarts Tumor Progression : Sunitinib, a drug that binds to multiple enzymes, offers new hope for patients resistant to imatinib.

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Targeted Therapy Thwarts Tumor Progression : Sunitinib, a drug that binds to multiple enzymes, offers new hope for patients resistant to imatinib.

User login

  • Reset your password
  • /content/targeted-therapy-thwarts-tumor-progression-sunitinib-drug-binds-multiple-enzymes-offers-new
  • /familypracticenews/article/27151/gastroenterology/targeted-therapy-thwarts-tumor-progression
  • /ehospitalistnews/article/27151/gastroenterology/targeted-therapy-thwarts-tumor-progression-sunitinib
  • /familymedicine/article/27151/gastroenterology/targeted-therapy-thwarts-tumor-progression-sunitinib